Medigen Biotechnology Corp. (TPEX:3176)
Taiwan · Delayed Price · Currency is TWD 30.25
+0.05 (0.17%)
At close: Mar 3, 2026
Medigen Biotechnology Market Cap
Medigen Biotechnology has a market cap or net worth of 4.21 billion as of March 3, 2026. Its market cap has decreased by -15.97% in one year.
Market Cap
4.21B
Enterprise Value
6.03B
Revenue
1.59B
Ranking
n/a
PE Ratio
n/a
Stock Price
30.25
Market Cap Chart
Since November 3, 2004, Medigen Biotechnology's market cap has increased from 684.56M to 4.21B, an increase of 515.58%. That is a compound annual growth rate of 8.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 4.21B | -6.79% |
| Dec 31, 2025 | 4.51B | - |
| Dec 31, 2024 | 4.51B | -27.70% |
| Dec 29, 2023 | 6.24B | 33.24% |
| Dec 30, 2022 | 4.69B | -41.43% |
| Dec 30, 2021 | 8.00B | -2.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharmosa Biopharm | 5.15B |
| BioGend Therapeutics | 4.58B |
| Senhwa Biosciences | 4.51B |
| Energenesis Biomedical CO.,LTD. | 4.26B |
| Formosa Pharmaceuticals | 4.20B |
| Intech Biopharm | 3.89B |
| ACRO Biomedical | 3.77B |
| Genovate Biotechnology | 3.62B |